Mogul Enterprises
This article was originally published in The Gray Sheet
Executive Summary
Firm's steerable decapolar electrophysiology diagnostic catheter receives FDA market go-ahead, Mogul announces Aug. 21. A limited U.S. launch will take place in four-to-six months, following an upgrade of the firm's manufacturing facility. The 3 Fr catheter will generally be priced 30% below the competition while offering more features and better performance, the privately held San Jose, California firm claims